rs372610945

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate

The NM_000116.5(TAFAZZIN):​c.660C>A​(p.Val220Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. V220V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 23)

Consequence

TAFAZZIN
NM_000116.5 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0310

Publications

0 publications found
Variant links:
Genes affected
TAFAZZIN (HGNC:11577): (tafazzin, phospholipid-lysophospholipid transacylase) This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]
TAFAZZIN Gene-Disease associations (from GenCC):
  • Barth syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant X-154420225-C-A is Benign according to our data. Variant chrX-154420225-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1800193.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000116.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAFAZZIN
NM_000116.5
MANE Select
c.660C>Ap.Val220Val
synonymous
Exon 9 of 11NP_000107.1Q16635-1
TAFAZZIN
NM_001440856.1
c.714C>Ap.Val238Val
synonymous
Exon 9 of 11NP_001427785.1
TAFAZZIN
NM_001303465.2
c.672C>Ap.Val224Val
synonymous
Exon 8 of 10NP_001290394.1A6XNE1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAFAZZIN
ENST00000601016.6
TSL:1 MANE Select
c.660C>Ap.Val220Val
synonymous
Exon 9 of 11ENSP00000469981.1Q16635-1
TAFAZZIN
ENST00000475699.6
TSL:1
c.624C>Ap.Val208Val
synonymous
Exon 8 of 10ENSP00000419854.3A0A499FJ53
TAFAZZIN
ENST00000369776.8
TSL:1
c.570C>Ap.Val190Val
synonymous
Exon 5 of 7ENSP00000358791.4F6Y2X3

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
23

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
7.6
DANN
Benign
0.75
PhyloP100
0.031
PromoterAI
0.27
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372610945; hg19: chrX-153648564; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.